High-sensitivity C-reactive protein in stroke patients - The importance in consideration of influence of multiple factors in the predictability for disease severity and death
High sensitivity C-reactive protein (hsCRP) has been evaluated as a biomarker in stroke and relevant pathological diseases. While its predictive values in several pathological phenotypes have been confirmed, controversy exists among different studies. This review summarizes reports of the predictive values of hsCRP for the diagnosis, etiology, prognosis and mortality of stroke diseases. The current literature suggests that CRP expression is influenced by multiple factors, such as polymorphisms, the genomic backgrounds and gender. However, few reported studies analyzed data based on all these multiple factors. Future studies should focus on comprehensive analysis based on multiple factors. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
基金：
First Hospital of Qiqihar City, Heilongjiang Province, PR China; National Natural Science Foundation of China, P.R. ChinaNational Natural Science Foundation of China [81372996]; Research to Prevent Blindness (New York, NY)Research to Prevent Blindness (RPB)
Yu Hong,Huang Yue,Chen Xinyu,et al.High-sensitivity C-reactive protein in stroke patients - The importance in consideration of influence of multiple factors in the predictability for disease severity and death[J].JOURNAL OF CLINICAL NEUROSCIENCE.2017,36:12-19.doi:10.1016/j.jocn.2016.10.020.
APA：
Yu, Hong,Huang, Yue,Chen, Xinyu,Nie, WenBao,Wang, YongJun...&Chen, Hong.(2017).High-sensitivity C-reactive protein in stroke patients - The importance in consideration of influence of multiple factors in the predictability for disease severity and death.JOURNAL OF CLINICAL NEUROSCIENCE,36,
MLA：
Yu, Hong,et al."High-sensitivity C-reactive protein in stroke patients - The importance in consideration of influence of multiple factors in the predictability for disease severity and death".JOURNAL OF CLINICAL NEUROSCIENCE 36.(2017):12-19
